AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Market Cap: 40.04M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 40.04M |
| November 21, 2024 | 36.75M |
| November 20, 2024 | 38.84M |
| November 19, 2024 | 31.67M |
| November 18, 2024 | 29.88M |
| November 15, 2024 | 29.88M |
| November 14, 2024 | 29.88M |
| November 13, 2024 | 30.18M |
| November 12, 2024 | 31.67M |
| November 11, 2024 | 32.57M |
| November 08, 2024 | 32.87M |
| November 07, 2024 | 32.87M |
| November 06, 2024 | 32.87M |
| November 05, 2024 | 32.56M |
| November 04, 2024 | 32.26M |
| November 01, 2024 | 32.26M |
| October 31, 2024 | 32.26M |
| October 30, 2024 | 32.56M |
| October 29, 2024 | 33.15M |
| October 28, 2024 | 32.86M |
| October 25, 2024 | 31.96M |
| October 24, 2024 | 31.96M |
| October 23, 2024 | 32.26M |
| October 22, 2024 | 32.26M |
| October 21, 2024 | 32.26M |
| Date | Value |
|---|---|
| October 18, 2024 | 31.36M |
| October 17, 2024 | 30.76M |
| October 16, 2024 | 31.66M |
| October 15, 2024 | 31.36M |
| October 14, 2024 | 30.76M |
| October 11, 2024 | 31.36M |
| October 10, 2024 | 31.06M |
| October 09, 2024 | 31.06M |
| October 08, 2024 | 31.06M |
| October 07, 2024 | 31.06M |
| October 04, 2024 | 31.96M |
| October 03, 2024 | 31.06M |
| October 02, 2024 | 31.36M |
| October 01, 2024 | 31.36M |
| September 30, 2024 | 31.96M |
| September 27, 2024 | 31.63M |
| September 26, 2024 | 31.48M |
| September 25, 2024 | 31.33M |
| September 24, 2024 | 31.04M |
| September 23, 2024 | 31.04M |
| September 20, 2024 | 31.33M |
| September 19, 2024 | 32.23M |
| September 18, 2024 | 31.63M |
| September 17, 2024 | 31.63M |
| September 16, 2024 | 31.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
29.25M
Minimum
Aug 16 2024
640.33M
Maximum
Jan 09 2024
222.34M
Average
179.67M
Median
Dec 21 2022
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.25B |
| Arbutus Biopharma Corp | 665.12M |
| GlycoMimetics Inc | 20.43M |
| FibroGen Inc | 39.84M |
| Cidara Therapeutics Inc | 143.75M |
Market Cap Related Metrics
| Price to Book Value | 0.4567 |
| Price | 1.34 |
| Earnings Yield | -152.2% |